Identification of genetic and epigenetic variations in a rat model for neurodevelopmental disorders

Behavior Genetics

Volumn 37, Issue 5, 2007, Pages 697-705

  Van Loo, Karen M J ^a   Martens, Gerard J M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

AP PCR; Aph 1b; APO SUS rat model; Genetic and epigenetic variations; Neurodevelopmental disorders

Indexed keywords

APOMORPHINE; DNA TOPOISOMERASE (ATP HYDROLYSING); GENOMIC DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CLUSTER ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DNA METHYLATION; EPIGENETICS; GENETIC DIFFERENCE; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HYPOTHALAMUS; NEURODEVELOPMENTAL DISORDER; NONHUMAN; PHENOTYPE; RAT;

ANIMALS; APOMORPHINE; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; MENTAL DISORDERS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RATS, WISTAR; SCHIZOPHRENIA; VARIATION (GENETICS);

RATTUS; RATTUS NORVEGICUS;

EID: 35148821787     PISSN: 00018244     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10519-007-9164-1     Document Type: Article

References (24)

1. Coolen MW, van Loo KM, Ellenbroek BA, Cools AR, Martens GJ (2006a) Ontogenic reduction of Aph-1b mRNA and gamma-secretase activity in rats with a complex neurodevelopmental phenotype. Mol Psychiatry 11:787-793
2. Coolen MW, van Loo KM, van Bakel NN, Ellenbroek BA, Cools AR, Martens GJ (2006b) Reduced Aph-1b expression causes tissue- and substrate-specific changes in gamma-secretase activity in rats with a complex phenotype. Faseb J 20:175-177
3. Coolen MW, Van Loo KM, Van Bakel NN, Pulford DJ, Serneels L, De Strooper B, Ellenbroek BA, Cools AR, Martens GJ (2005) Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders. Neuron 45:497-503
4. Cools AR, Brachten R, Heeren D, Willemen A, Ellenbroek B (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24:49-69
5. Craig NL, Nash HA (1983) The mechanism of phage lambda site-specific recombination: site-specific breakage of DNA by Int topoisomerase. Cell 35:795-803
6. Ellenbroek BA, Cools AR (2002) Apomorphine susceptibility and animal models for psychopathology: genes and environment. Behav Genet 32:349-361
7. Ellenbroek BA, Geyer MA, Cools AR (1995) The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci 15:7604-7611
8. Ellenbroek BA, Sluyter F, Cools AR (2000) The role of genetic and early environmental factors in determining apomorphine susceptibility. Psychopharmacology (Berl) 148:124-131
9. Goldstein MJ (1987) Psychosocial issues. Schizophr Bull 13:157-171
10. Gottesman I (1991) Schizophrenia genesis: the origins of madness. W.H. Freeman and Company, New York
11. Jablensky A, Sartorius N, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1987) Incidence worldwide of schizophrenia. Br J Psychiatry 151:408-409
12. Jeanneteau F, Diaz J, Sokoloff P, Griffon N (2004) Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. Mol Biol Cell 15:696-705
13. Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253-262
14. Kavelaars A, Heijnen CJ, Ellenbroek B, van Loveren H, Cools A (1997) Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in their susceptibility to inflammatory and infectious diseases: a study on rats with group-specific differences in structure and reactivity of hypothalamic-pituitary-adrenal axis. J Neurosci 17:2580-2584
15. Kay SR, Opler LA (1987) The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 5:79-103
16. Mednick SA, Machon RA, Huttunen MO, Bonett D (1988) Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189-192
17. Nadeau JH (2001) Modifier genes in mice and humans. Nat Rev Genet 2:165-174
18. Nadeau JH, Topol EJ (2006) The genetics of health. Nat Genet 38:1095-1098
19. Regland B (2005) Schizophrenia and single-carbon metabolism. Prog Neuropsychopharmacol Biol Psychiatry 29:1124-1132
20. Rots NY, Cools AR, de Jong J, De Kloet ER (1995) Corticosteroid feedback resistance in rats genetically selected for increased dopamine responsiveness. J Neuroendocrinol 7:153-161
21. Spitzner JR, Muller MT (1988) A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Res 16:5533-5556
22. Van de Vijver G, Van Speybroeck L, De Waele D (2002) Epigenetics: a challenge for genetics, evolution, and development? Ann N Y Acad Sci 981:1-6
23. Welsh J, McClelland M (1990) Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18:7213-7218
24. Wolffe AP, Matzke MA (1999) Epigenetics: regulation through repression. Science 286:481-486